Can you provide the market/opportunity size for Ibuprofen in USA and Canada which would qualify this as breaking news?
Tried searching on Google, see mostly paid research reports.
Can you provide the market/opportunity size for Ibuprofen in USA and Canada which would qualify this as breaking news?
Tried searching on Google, see mostly paid research reports.
I have readjusted my portfolio. Once i had 50+ companies in my portfolio. I have concentrated it in the recent correction. I have come out of many minor holdings and reinvested it. Below is my latest portfolio. Views are most welcome.
BRITANNIA 13
PIIND 12
YESBANK 12
MAX 8
AMARAJABAT 6
CYIENT 6
HINDPETRO 6
LICHSGFIN 6
SUNPHARMA 6
FINCABLES 5
MOTHERSUMI 5
APLLTD 3
KRBL 3
PAUSHAKLTD 3
I have readjusted my portfolio. Once i had 50+ companies in my portfolio. I have concentrated it in the recent correction. I have come out of many minor holdings and reinvested it. Below is my latest portfolio. Views are most welcome.
BRITANNIA 13
PIIND 12
YESBANK 12
MAX 8
AMARAJABAT 6
CYIENT 6
HINDPETRO 6
LICHSGFIN 6
SUNPHARMA 6
FINCABLES 5
MOTHERSUMI 5
APLLTD 3
KRBL 3
PAUSHAKLTD 3
Varun..what is inspiring is your 150% return
Breaking news !!
http://www.bseindia.com/xml-data/corpfiling/AttachLive/F28F9608_D947_4BFE_B14D_9E46CF6659B9_164540.pdf
Granules receives FDA nod for ibuprofen
Hi Varun,
Axis Bank is a recent addition your portfolio any reason for giving it preference over HDFC bank.
Regards,
kapil
On a ligher note what inspires you in my portfolio. I always see a very
concentrated portfolio of about 10-12 stocks and to my surprise 70-80% of
stocks in almost all portfolio are same.
Sometimes I wonder whether I am correct
With Thanks & Best Regards
Varun Jain
Associate Architect
ARCOP
Mob – 09910507431
Off – 01126242050,
Alt email-ID –
Work – vjain@arcop.co.in
What is your take on – http://www.firstpost.com/business/going-to-office-as-a-10-year-old-was-not-a-chore-says-muthoot-finance-md-george-muthoot-2420978.html
Specifically this – We are getting into the realm of housing finance and are looking at a niche customer base. Our gold customers could be the potential customers here as well. We have at any given time Rs 60 lakhs of gold loans. Our emphasis is on affordable housing. We are not here to compete with the SBIs or any similar entities in that space.
This new area for them would have much longer tenure loans compared to the existing ones they make with lower spreads compared to their core business
There are synergies between what they do and this new field in terms of negligible customer acquisition cost but this is a very different ball game.
Can you think of specific reasons why management is thinking this way because till now they have been very smart about capital allocation. we may argue about when this new business will start/frustify/scale but I am more interested in why would management even contemplate this move in the first place
Thanks
In case your growth projection rate of 18% is correct then there is 57%
margin of safety calculated on 15 PE. Dont calculate on 18 PE.
Your formula seems to be incorrect
Refer attached one
With Thanks & Best Regards
Varun Jain
Associate Architect
ARCOP
Mob – 09910507431
Off – 01126242050,
Alt email-ID –
Work – vjain@arcop.co.in
Copy of Intrinsic value calculation Aarti drugs 16 09 2015.xlsx (18.3 KB)
Plz share aarti drugs last 10 yrs eps and book value if you have for me to
chk
With Thanks & Best Regards
Varun Jain
Associate Architect
ARCOP
Mob – 09910507431
Off – 01126242050,
Alt email-ID –
Work – vjain@arcop.co.in
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!